Agathe Mouheb
@agathemouheb.bsky.social
PhD Student | MSB | Biostatistician
💡 Key findings:
📌 40% of ULT prescriptions were inappropriate based on kidney function.
📌 70% of these inappropriate prescriptions were not reassessed over 5 years.
📌 No significant association between ULT and slower CKD progression.
📌 40% of ULT prescriptions were inappropriate based on kidney function.
📌 70% of these inappropriate prescriptions were not reassessed over 5 years.
📌 No significant association between ULT and slower CKD progression.
April 14, 2025 at 3:44 PM
💡 Key findings:
📌 40% of ULT prescriptions were inappropriate based on kidney function.
📌 70% of these inappropriate prescriptions were not reassessed over 5 years.
📌 No significant association between ULT and slower CKD progression.
📌 40% of ULT prescriptions were inappropriate based on kidney function.
📌 70% of these inappropriate prescriptions were not reassessed over 5 years.
📌 No significant association between ULT and slower CKD progression.
📌 Our findings emphasize the importance of reassessing anticholinergic prescriptions in CKD patients to mitigate cognitive risks.
🖱️ Interested in the full study? Explore it here: doi.org/10.1111/jgs....
🖱️ Interested in the full study? Explore it here: doi.org/10.1111/jgs....
The anticholinergic burden in patients with chronic kidney disease: Patterns, risk factors, and the link with cognitive impairment
Background People with chronic kidney disease (CKD) have an elevated risk of cognitive impairment (CI). Medications with anticholinergic activity are recognized for their adverse reactions on centra...
doi.org
December 10, 2024 at 9:48 AM
📌 Our findings emphasize the importance of reassessing anticholinergic prescriptions in CKD patients to mitigate cognitive risks.
🖱️ Interested in the full study? Explore it here: doi.org/10.1111/jgs....
🖱️ Interested in the full study? Explore it here: doi.org/10.1111/jgs....
December 4, 2024 at 5:34 PM
📊 Findings highlight the frequent use of anticholinergic drugs in CKD and their potential impact on cognition.
#CKD #Nephrology #Pharmacology #CKDREINcohort #AnticholinergicBurden #CognitiveImpairment
#CKD #Nephrology #Pharmacology #CKDREINcohort #AnticholinergicBurden #CognitiveImpairment
December 4, 2024 at 5:33 PM
📊 Findings highlight the frequent use of anticholinergic drugs in CKD and their potential impact on cognition.
#CKD #Nephrology #Pharmacology #CKDREINcohort #AnticholinergicBurden #CognitiveImpairment
#CKD #Nephrology #Pharmacology #CKDREINcohort #AnticholinergicBurden #CognitiveImpairment
🔍We explored the link between anticholinergic drug burden and cognitive impairment in patients with chronic kidney disease (CKD).
👥 Using data from the French CKD-REIN cohort, which includes 3,033 patients under nephrology care (non-dialyzed, non-transplanted).
👥 Using data from the French CKD-REIN cohort, which includes 3,033 patients under nephrology care (non-dialyzed, non-transplanted).
December 4, 2024 at 5:33 PM
🔍We explored the link between anticholinergic drug burden and cognitive impairment in patients with chronic kidney disease (CKD).
👥 Using data from the French CKD-REIN cohort, which includes 3,033 patients under nephrology care (non-dialyzed, non-transplanted).
👥 Using data from the French CKD-REIN cohort, which includes 3,033 patients under nephrology care (non-dialyzed, non-transplanted).